Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
Rott RolandCEO, Ultrasound
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,886 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · derivative · entry 5 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,886 Underlying: Common Stock, par value $0.01 per share · 11,886 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
Rott RolandCEO, Ultrasound
|
GrantCommon Stock, par value $0.01 per share | 4,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,666 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 2,169 | $91.28 | $197,986.32 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,487 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,457 | $91.28 | $132,994.96 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,656 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 929 | $91.28 | $84,799.12 |
DisclosureSEC source: 0001628280-24-009082 · wk-form4_1709679280.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,113 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,202 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · derivative · entry 7 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,202 Underlying: Common Stock, par value $0.01 per share · 9,202 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantCommon Stock, par value $0.01 per share | 3,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 5 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,059 | $91.28 | $279,225.52 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,775 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,717 | $91.28 | $156,727.76 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,834 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 2,140 | $91.28 | $195,339.20 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,551 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,309 | $91.28 | $119,485.52 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,691 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,067 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · derivative · entry 7 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,067 Underlying: Common Stock, par value $0.01 per share · 3,067 shares Expires 2034-03-01 F6 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F6 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantCommon Stock, par value $0.01 per share | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · nonDerivative · entry 5 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,570 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F5 · balance_after: Effective as of January 19, 2024, GE HealthCare removed the GE HealthCare stock fund as an investment option under the 401(k) plan, the GE HealthCare Retirement Savings Plan ("RSP"). As a result, the shares of GE HealthCare common stock the reporting person previously reported as beneficially owned under the RSP were liquidated. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 997 | $91.28 | $91,006.16 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · nonDerivative · entry 4 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,492 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 589 | $91.28 | $53,763.92 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · nonDerivative · entry 3 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,489 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 565 | $91.28 | $51,573.20 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · nonDerivative · entry 2 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,078 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 381 | $91.28 | $34,777.68 |
DisclosureSEC source: 0001628280-24-009079 · wk-form4_1709679225.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,643 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,006 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · derivative · entry 6 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,006 Underlying: Common Stock, par value $0.01 per share · 23,006 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
GrantCommon Stock, par value $0.01 per share | 8,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 5 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,348 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 8,154 | $91.28 | $744,297.12 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 4 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,260 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 4,292 | $91.28 | $391,773.76 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 3 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,414 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,424 | $91.28 | $312,542.72 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 2 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,706 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:53 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,489 | $91.28 | $318,475.92 |
DisclosureSEC source: 0001628280-24-009078 · wk-form4_1709679200.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,130 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,374 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009075 · wk-form4_1709679137.xml · derivative · entry 2 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,374 Underlying: Common Stock, par value $0.01 per share · 28,374 shares Expires 2034-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:52 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantCommon Stock, par value $0.01 per share | 9,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009075 · wk-form4_1709679137.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,600 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 21, 2024 Filed Feb 21, 2024 21:48 UTC |
GENERAL ELECTRIC CO10% owner
|
OtherCommon stock, par value $0.01 per share | 14,950,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-24-000506 · es240449620_4-ge.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,631,302 F1 · security: The reporting person exchanged 14,950,000 shares of the common stock of the Issuer to extinguish $1,229,637,500 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F1 · kind: The reporting person exchanged 14,950,000 shares of the common stock of the Issuer to extinguish $1,229,637,500 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F2 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $82.25 per share. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 21:15 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 7,805 | $74.35 | $580,301.75 |
DisclosureSEC source: 0001628280-24-003493 · wk-form4_1707254107.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,624 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 16:17 UTC |
Stacherski Kenneth R.Ch. Supply Chain & Serv. Ofc.
|
Tax withholdingCommon Stock, par value $0.01 per share | 7,157 | $67.23 | $481,165.11 |
DisclosureSEC source: 0001889865-23-000006 · wk-form4_1699042663.xml · nonDerivative · entry 1 Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,831 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:06 UTC |
Rott RolandCEO, Ultrasound
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,630 | $76.19 | $124,189.70 |
DisclosureSEC source: 0001628280-23-027763 · wk-form4_1691438781.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,705 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,532 | $76.19 | $116,723.08 |
DisclosureSEC source: 0001628280-23-027761 · wk-form4_1691438746.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,493 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:05 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 4,596 | $76.19 | $350,169.24 |
DisclosureSEC source: 0001628280-23-027759 · wk-form4_1691438712.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,271 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,275 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 13,275 shares Expires 2028-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis, of which 100% are fully exercisable immediately. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
SaleCommon Stock, par value $0.01 per share | 13,275 | $77.46 | $1,028,281.50 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,025 F2 · kind: Includes sale of approximately 6,923 shares of GE HealthCare common stock to cover the exercise price of the stock options. F3 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.45 to $77.55, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3). Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Exercise / conversionCommon Stock, par value $0.01 per share | 13,275 | $40.40 | $536,310.00 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC |
O'Neill Kevin MichaelCEO, PDx
|
SaleCommon Stock, par value $0.01 per share | 2,334 | $76.55 | $178,667.70 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,025 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.55 to $76.59, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:07 UTC |
Makela JanCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,929 | $80.36 | $155,014.44 |
DisclosureSEC source: 0001628280-23-024233 · wk-form4_1688587655.xml · nonDerivative · entry 1 Makela Jan · CIK 0001951803 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,867 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 23, 2023 Filed Jun 23, 2023 20:04 UTC |
GENERAL ELECTRIC CO10% owner
|
OtherCommon stock, par value $0.01 per share | 1,218,685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-23-001794 · es230372269_4-ge.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,581,302 F1 · security: Pursuant to an underwriting agreement dated June 7, 2023, the underwriters exercised their option to purchase an additional 1,218,685 shares of the common stock of the Issuer. F2 · security: The reporting person exchanged 1,218,685 shares of the common stock of the Issuer to extinguish $95,057,430 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F1 · kind: Pursuant to an underwriting agreement dated June 7, 2023, the underwriters exercised their option to purchase an additional 1,218,685 shares of the common stock of the Issuer. F2 · kind: The reporting person exchanged 1,218,685 shares of the common stock of the Issuer to extinguish $95,057,430 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F3 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $78.00 per share. Read SEC document |
| June 14, 2023 Filed Jun 14, 2023 20:03 UTC |
GENERAL ELECTRIC CO10% owner
|
OtherCommon stock, par value $0.01 per share | 2,531,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-23-001686 · es230369656_4-ge.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,799,987 F1 · security: Pursuant to an underwriting agreement dated June 7, 2023, the underwriters exercised their option to purchase an additional 2,531,315 shares of the common stock of the Issuer. F2 · security: The reporting person exchanged 2,531,315 shares of the common stock of the Issuer to extinguish $197,442,570 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F1 · kind: Pursuant to an underwriting agreement dated June 7, 2023, the underwriters exercised their option to purchase an additional 2,531,315 shares of the common stock of the Issuer. F2 · kind: The reporting person exchanged 2,531,315 shares of the common stock of the Issuer to extinguish $197,442,570 aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F3 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $78.00 per share. Read SEC document |
| June 12, 2023 Filed Jun 12, 2023 20:02 UTC |
GENERAL ELECTRIC CO10% owner
|
OtherCommon stock, par value $0.01 per share | 25,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-23-001670 · es230359141_4-ge.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,331,302 F1 · security: The reporting person exchanged 25,000,000 shares of the common stock of the Issuer to extinguish $1,950 million aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F1 · kind: The reporting person exchanged 25,000,000 shares of the common stock of the Issuer to extinguish $1,950 million aggregate principal amount of indebtedness under a short-term credit facility of the reporting person in a debt-for-equity exchange. F2 · price: The value of the Issuer's common stock for purposes of the debt-for-equity exchange was $78.00 per share. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:06 UTC |
Rott RolandCEO, Ultrasound
|
SaleCommon Stock, par value $0.01 per share | 2,473 | $77.37 | $191,336.01 |
DisclosureSEC source: 0001628280-23-021856 · wk-form4_1686600346.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Ultrasound 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,335 Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:31 UTC |
SACCARO JAMESChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 54,472 | Not disclosed Strike: $79.83 | Not disclosed |
DisclosureSEC source: 0001628280-23-020935 · wk-form4_1686000668.xml · derivative · entry 5 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,472 Underlying: Common Stock, par value $0.01 per share · 54,472 shares Expires 2033-06-01 F6 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F6 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:31 UTC |
SACCARO JAMESChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 36,176 | Not disclosed Strike: $79.83 | Not disclosed |
DisclosureSEC source: 0001628280-23-020935 · wk-form4_1686000668.xml · derivative · entry 4 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,176 Underlying: Common Stock, par value $0.01 per share · 36,176 shares Expires 2033-06-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:31 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 5,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020935 · wk-form4_1686000668.xml · nonDerivative · entry 3 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,693 F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F4 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:31 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 11,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020935 · wk-form4_1686000668.xml · nonDerivative · entry 2 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,743 F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:31 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 43,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020935 · wk-form4_1686000668.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,843 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on June 1, 2024 and 50% will vest on June 1, 2025. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:29 UTC |
LAVIZZO-MOUREY RISA JDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019777 · wf-form4_168504654928723.xml · nonDerivative · entry 1 LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,625 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:31 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 1,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019789 · wf-form4_168504668536448.xml · nonDerivative · entry 2 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,798 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:31 UTC |
Madden Anne TDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019789 · wf-form4_168504668536448.xml · nonDerivative · entry 1 Madden Anne T · CIK 0001684059 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:30 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 1,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019785 · wf-form4_168504662653038.xml · nonDerivative · entry 2 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,798 F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the director's applicable deferral election. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:30 UTC |
Hochman Rodney FDirector
|
GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019785 · wf-form4_168504662653038.xml · nonDerivative · entry 1 Hochman Rodney F · CIK 0001468966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.